Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Liang Lu

Showing results (281-290 of 322) with videos related to

Pageof 33
Sort By:
Open Forum Infectious Diseases|September 3, 2020
Viral Interference Between Dengue Virus and Hepatitis C Virus InfectionsPo-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, et al.
International Journal of Antimicrobial Agents|July 21, 2021
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIVYu-Lin Lee, Kuan-Yin Lin, Shu-Hsing Cheng, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010Han-Siong Toh, Yin-Ching Chuang, Chi-Chang Huang, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010Yu-Lin Lee, Yao-Shen Chen, Han-Siong Toh, et al.
Scientific Reports|September 27, 2022
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-upKuan-Yin Lin, Chia-Jui Yang, Hsin-Yun Sun, et al.
The Lancet. Microbe|July 2, 2026
Lineage-specific transmission and spatial clustering of Mycobacterium tuberculosis in Kaohsiung, Taiwan, in 2019-23: a population-based genomic studyChieh-Yin Wu, Ying-An Chen, Thomas R Ioerger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2020
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, et al.
Microbiology Spectrum|March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2024
Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomesRou-Zhen Chen, Po-Liang Lu, Tsung-Ying Yang, et al.
IJID Regions|March 11, 2026
Exploring HIV care disparities among foreigners in Taiwan: Insights from a multicenter study (2017-2023)Sung-Hsi Huang, Shu-Ying Chang, Bo-Huang Liou, et al.
Pageof 33

Showing results (281-290 of 322) with videos related to

Sort By:
Pageof 33
Open Forum Infectious Diseases|September 3, 2020
Viral Interference Between Dengue Virus and Hepatitis C Virus InfectionsPo-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, et al.
International Journal of Antimicrobial Agents|July 21, 2021
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIVYu-Lin Lee, Kuan-Yin Lin, Shu-Hsing Cheng, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010Han-Siong Toh, Yin-Ching Chuang, Chi-Chang Huang, et al.
International Journal of Antimicrobial Agents|July 4, 2012
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010Yu-Lin Lee, Yao-Shen Chen, Han-Siong Toh, et al.
Scientific Reports|September 27, 2022
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-upKuan-Yin Lin, Chia-Jui Yang, Hsin-Yun Sun, et al.
The Lancet. Microbe|July 2, 2026
Lineage-specific transmission and spatial clustering of Mycobacterium tuberculosis in Kaohsiung, Taiwan, in 2019-23: a population-based genomic studyChieh-Yin Wu, Ying-An Chen, Thomas R Ioerger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2020
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Bo-Huang Liou, et al.
Microbiology Spectrum|March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2024
Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomesRou-Zhen Chen, Po-Liang Lu, Tsung-Ying Yang, et al.
IJID Regions|March 11, 2026
Exploring HIV care disparities among foreigners in Taiwan: Insights from a multicenter study (2017-2023)Sung-Hsi Huang, Shu-Ying Chang, Bo-Huang Liou, et al.
Pageof 33